RESUMO
Bisphenol S (BPS), an analogue of the controversial bisphenol A (BPA) that is found in epoxy resins and plastics, is a potential endocrine-disrupting chemical that can mimic endogenous hormone signaling. However, little is known about the behavioral or immunologic effects of BPS. The purpose of this study was to examine the impact of diets in BPS-treated mice in relation to hyperglycemia, development of type 1 diabetes, immunomodulation, and behavioral changes. Adult male and female nonobese diabetic excluded flora (NODEF) mice were exposed to environmentally relevant doses of BPS (VH, 30, or 300 µg/kg BW) and fed either a soy-based diet, a phytoestrogen-free diet, or a Western diet. NODEF male mice fed a soy-based diet exhibited a decreased curiosity/desire to explore, and possibly increased anxiety-like behavior and decreased short-term memory when exposed to BPS (300 µg/kg BW). In addition, these mice had significant increases in non-fasting blood glucose levels along with increased insulin sensitivity, impaired glucose tolerance, resistance to fasting and proinflammation. Although BPS had little effect on the glucose parameters in NODEF male mice fed a Western diet, there were decreases in %CD24+CD5+ and %B220+CD40L-cell populations and increases in distance traveled during the novel object test, suggesting hyperactivity. NODEF females fed a phytoestrogen-free diet exhibited slight decreases in time spent immobile during the tail suspension test in both the 30 and 300 µg/kg BW dose groups along with increases in %CD4+CD8+ and %Mac3+CD45R+ cell populations, signifying increased hyperactivity and anxiety-like behavior. In conclusion, BPS-exposed NODEF mice exhibited sex and diet-related changes in hyperglycemia, behaviors and immune endpoints.
Assuntos
Dieta Ocidental/efeitos adversos , Hiperglicemia/metabolismo , Hipercinese/metabolismo , Fenóis/toxicidade , Alimentos de Soja/efeitos adversos , Sulfonas/toxicidade , Animais , Glicemia/metabolismo , Dieta Ocidental/psicologia , Disruptores Endócrinos/toxicidade , Feminino , Hiperglicemia/induzido quimicamente , Hiperglicemia/psicologia , Hipercinese/induzido quimicamente , Hipercinese/psicologia , Masculino , Camundongos , Camundongos Endogâmicos NOD , Fitoestrógenos/administração & dosagem , Fitoestrógenos/efeitos adversosRESUMO
Resveratrol is a naturally occurring polyphenol that is being investigated to treat and prevent various diseases, both experimentally and in the clinic. Despite increased use and interest in resveratrol due to its immunomodulatory properties, there is a lack of studies evaluating potential toxicities, particularly immunotoxicity, associated with resveratrol use. A previous 2-week study found decreasing thymus weight in male B6C3F1/N mice with increasing exposure to trans-resveratrol. This study is a follow-up on those findings by evaluating immune function. Male adult B6C3F1/N mice were given trans-resveratrol (0, 156, 312, 625, 1250, 2500 mg/kg/day) via oral gavage for 28 days and functional immune tests and histopathology were evaluated. There were no treatment-related effects on body weight during the study. Humoral, cell-mediated, and innate immune function were not altered after 28 days of trans-resveratrol treatment. There were also no changes in organ weight or microscopic alterations in immune organs. Overall, under the conditions of this study, there was no evidence of immunotoxicity or improvements in immune function associated with oral exposure to trans-resveratrol in male mice. Importantly, the immunomodulatory benefits of resveratrol may require a prerequisite level of inflammatory activity and may not be observable in healthy individuals.
Assuntos
Suplementos Nutricionais/efeitos adversos , Sistema Imunitário/efeitos dos fármacos , Fatores Imunológicos/efeitos adversos , Resveratrol/efeitos adversos , Timo/patologia , Administração Oral , Animais , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Imunidade Celular , Imunidade Humoral , Imunidade Inata , Fatores Imunológicos/administração & dosagem , Masculino , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Resveratrol/administração & dosagem , Timo/efeitos dos fármacosRESUMO
Daidzein (DAZ), a dominant isoflavone in various natural products such as soybeans, has been gaining attention due to the beneficial health effects (e.g., protection against cancer and diabetes) of its metabolites. Our major hypothesis was that dietary exposure to the soy phytoestrogen DAZ could modulate the immune responses toward a protective effect and lead to improved metabolic functions (such as glucose metabolism). In this study, we applied complementary mouse models, the hybrid B6C3F1 and inbred type 1 diabetes prone non-obese diabetic (NOD) mice, to investigate if DAZ exposure modulated the immune responses. The animals were orally administered DAZ at various physiological doses (2-20â¯mg/kg body weight) during adulthood. DAZ significantly altered the relative organ weights in female B6C3F1 mice and decreased the B cell population (represented by CD3-IgM+), while the T cell populations (represented by CD3+IgM-, CD4+CD8- and CD4-CD8+) were increased. In addition, DAZ dosing produced a decrease in the percentage of late apoptotic thymocytes. However, the activities cytotoxic T cells and natural killer cells were not altered in the B6C3F1 mice. In NOD mice, the blood glucose level and glucose tolerance were not affected by DAZ exposure, but DAZ modulated the antibody production, as shown by increased levels of IgG2b in NOD females and IgG1 in NOD males. Further, DAZ increased CD8+CD25+ splenocytes in NOD females. Taken together, DAZ induced an immunomodulatory effect in both NOD and B6C3F1 mouse strains; however, minimal effects on glucose homeostasis were observed.
Assuntos
Linfócitos B/imunologia , Isoflavonas/administração & dosagem , Fitoestrógenos/administração & dosagem , Linfócitos T/imunologia , Animais , Formação de Anticorpos , Diabetes Mellitus Tipo 1/imunologia , Suplementos Nutricionais , Feminino , Glucose/metabolismo , Homeostase , Imunomodulação , Masculino , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos NOD , Glycine max/imunologiaRESUMO
Although studies have linked soy phytoestrogen 4,7,4-trihydroxyisoflavone genistein (GEN) to reduced type 1 diabetes (T1D) risk, the mechanism of dietary GEN on T1D remains unknown. In our studies, adult non-obese diabetic (NOD) mouse model was employed to investigate the effects of GEN exposure on blood glucose level (BGL), glucose tolerance, gut microbiome, and immune responses. Adult male and female NOD mice were fed with either soy-based or casein-based diet, and received GEN at 20mg/kg body weight by gavage daily. The BGL and immune responses (represented by serum antibodies, cytokines and chemokines, and histopathology) were monitored, while the fecal gut microbiome was sequenced for 16S ribosomal RNA to reveal any alterations in gut microbial communities. A significantly reduced BGL was found in NOD males fed with soy-based diet on day 98 after initial dosing, and an improved glucose tolerance was observed on both diets. In addition, an anti-inflammatory response (suggested by reduced IgG2b and cytokine/chemokine levels, and alterations in the microbial taxonomy) was accompanied by an altered ß-diversity in gut microbial species. Among the NOD females exposed to GEN, a later onset of T1D was observed. However, the profiles of gut microbiome, antibodies and cytokines/chemokines were all indicative of pro-inflammation. This study demonstrated an association among GEN exposure, gut microbiome alteration, and immune homeostasis in NOD males. Although the mechanisms underlying the protective effects of GEN in NOD mice need to be explored further, the current study suggested a GEN-induced sex-specific effect in inflammatory status and gut microbiome.
Assuntos
Microbioma Gastrointestinal , Genisteína/farmacologia , Intolerância à Glucose/tratamento farmacológico , Hiperglicemia/prevenção & controle , Animais , Glicemia/metabolismo , Diabetes Mellitus Tipo 1/prevenção & controle , Fezes/química , Fezes/microbiologia , Feminino , Trato Gastrointestinal/efeitos dos fármacos , Trato Gastrointestinal/microbiologia , Homeostase/efeitos dos fármacos , Insulina/sangue , Masculino , Camundongos , Camundongos Endogâmicos NOD , Fitoestrógenos/farmacologia , Análise de Sequência de DNARESUMO
The objective of this study was to determine the effects of the phytoestrogen genistein (GEN) on the time of onset and/or the incidence of type 1 diabetes (T1D) in female nonobese diabetic (NOD) mice, when administered GEN by gavage once every day for up to 180 days. Five groups of mice (approximately 24 animals/group; 6-7 weeks of age) were included: naive control, vehicle control (25 mM Na2CO3 in water), and 3 GEN treatment groups (2 mg/kg, 6 mg/kg, and 20 mg/kg). Mice were maintained on a soy- and alfalfa-free diet (5K96) during the study and were monitored for blood glucose changes every week. When compared to the vehicle control, exposure to 2-mg/kg GEN produced significant decreases ranging from 55 to 79% in the total incidences of diabetes (blood glucose ≥ 250 mg/dl) and severe diabetes (blood glucose ≥ 400 mg/dl) starting at week 14 of the study. However, during the later stages of the study (i.e., after week 23), the 2-mg/kg dose had no effect on disease incidence. In animals treated with 6-mg/kg and 20-mg/kg GEN, significant decreases in the total incidence of diabetes were observed starting at week 16, while the incidence of severe diabetes was significantly decreased with the changes being observed initially at weeks 18 and 17 for the 6-mg/kg and 20-mg/kg GEN treatment groups, respectively. Several lines of evidence, including histopathological analysis, suggested that GEN protected the pancreas from autoimmune destruction. However, this protective effect of GEN was absent when female NOD mice were maintained on NTP-2000 rodent diet, which contained 5% soybean meal and 7.5% alfalfa meal (the total concentrations of phytoestrogens ranged between 95 and 134 mg/kg). In summary, oral dosing of GEN reduced the incidence and increased the time to onset of T1D in female NOD mice but only when fed a soy- and alfalfa-free diet.
Assuntos
Diabetes Mellitus Tipo 1/prevenção & controle , Genisteína/farmacologia , Glycine max , Medicago sativa , Fitoestrógenos/farmacologia , Animais , Autoanticorpos/análise , Glicemia/metabolismo , Creatinina/sangue , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/patologia , Diabetes Mellitus Experimental/psicologia , Diabetes Mellitus Tipo 1/patologia , Dieta , Feminino , Insulina/sangue , Insulina/imunologia , Rim/patologia , Camundongos , Camundongos Endogâmicos NOD , Pâncreas/patologiaRESUMO
Diet and phytoestrogens affect the development and progression of diabetes. The objective of the present study was to determine if oral exposure to phytoestrogen genistein (GE) by gavage changed blood glucose levels (BGL) through immunomodulation in streptozotocin (STZ)-induced diabetic male B6C3F1 mice fed with three different diets. These three diets were: NTP-2000 diet (NTP), soy- and alfalfa-free 5K96 diet (SOF) and high fat diet (HFD) with 60% of kcal from fat, primarily rendered fat of swine. The dosing regimen for STZ consisted of three 100mg/kg doses (i.p.): the first dose was administered at approximately 2weeks following the initiation of daily GE (20mg/kg) gavage, and the second dose was on day 19 following the first dose, and the third dose was on day 57 following the first dose. In mice on the NTP diet, GE treatment decreased BGL with statistical significances observed on days 33 and 82 following the first STZ injection. In mice fed the HFD diet, GE treatment produced a significant decrease and a significant increase in BGL on days 15 and 89 following the first STZ injection, respectively. In mice fed the SOF diet, GE treatment had no significant effects on BGL. Although GE treatment affected phenotypic distributions of both splenocytes (T cells, B cells, natural killer cells and neutrophils) and thymocytes (CD4/CD8 and CD44/CD25), and their mitochondrial transmembrane potential and generation of reactive oxygen species, indicators of cell death (possibly apoptosis), GE modulation of neutrophils was more consistent with its diabetogenic or anti-diabetic potentials. The differential effects of GE on BGL in male B6C3F1 mice fed with three different diets with varied phytoestrogen contents suggest that the estrogenic properties of this compound may contribute to its modulation of diabetes.
Assuntos
Glicemia/imunologia , Diabetes Mellitus Experimental/induzido quimicamente , Genisteína/farmacologia , Fitoestrógenos/farmacologia , Estreptozocina/administração & dosagem , Animais , Contagem de Células Sanguíneas , Glicemia/análise , Cruzamentos Genéticos , Diabetes Mellitus Experimental/imunologia , Dieta , Feminino , Citometria de Fluxo , Masculino , Potenciais da Membrana/imunologia , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Baço/citologia , Baço/imunologia , Estatísticas não Paramétricas , Timo/citologia , Timo/imunologiaRESUMO
The present studies were performed to examine the contact allergenic effects of an annatto extract (ANT) in female BALB/c mice. ANT at 5-10% induced a greater than threefold increase in lymph node cell proliferation when compared to the control in the LLNA. Moreover, a significant increase in the percent ear swelling at 24h after ANT challenge was observed in the MEST. A significant increase in the percentage of B cells was also observed. To determine which of the two predominant coloring components (norbixin and bixin) in ANT was responsible for the sensitizing effects of ANT, norbixin was subsequently examined, with negative results being observed in both the LLNA and MEST following treatment with norbixin (1-20%). These findings suggested that perhaps bixin was responsible for the positive responses in both the LLNA and MEST following exposure to ANT. Therefore, further studies using a partially purified cis-bixin extract were conducted. Positive responses in both the LLNA and MEST were observed in mice treated with cis-bixin at the concentrations as low as 0.1-0.5%. These results have demonstrated that cis-bixin, but not norbixin, is likely a contact sensitizer and contributes to the contact hypersensitivity effects observed following dermal exposure to ANT in mice.
Assuntos
Bixaceae/toxicidade , Carotenoides/toxicidade , Dermatite de Contato/etiologia , Corantes de Alimentos/toxicidade , Extratos Vegetais/toxicidade , Animais , Feminino , Citometria de Fluxo , Ensaio Local de Linfonodo , Camundongos , Camundongos Endogâmicos BALB C , Distribuição AleatóriaRESUMO
A thiazolidine-2,4-dione derivative, 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione (2), was identified as a dual inhibitor of the Raf/MEK/ extracellular signal-regulated kinase (ERK) and the phosphatidylinositol 3-kinase (PI3K)/Akt signaling cascades. The discovered compound inhibited cell proliferation, induced early apoptosis, and arrested cells in G(0)/G(1) phase in human leukemia U937 cells. These results indicate its potential as a new lead compound to develop novel dual signaling pathway inhibitors and anticancer agents.
Assuntos
Inibidores de Fosfoinositídeo-3 Quinase , Inibidores de Proteínas Quinases/química , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Transdução de Sinais/efeitos dos fármacos , Tiazolidinas/química , Linhagem Celular Tumoral , Avaliação Pré-Clínica de Medicamentos , MAP Quinases Reguladas por Sinal Extracelular/antagonistas & inibidores , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Humanos , Quinases de Proteína Quinase Ativadas por Mitógeno/antagonistas & inibidores , Quinases de Proteína Quinase Ativadas por Mitógeno/metabolismo , Fosfatidilinositol 3-Quinase/metabolismo , Inibidores de Proteínas Quinases/farmacologia , Proteínas Serina-Treonina Quinases/metabolismo , Proteínas Proto-Oncogênicas c-akt/antagonistas & inibidores , Proteínas Proto-Oncogênicas c-akt/metabolismo , Proteínas Proto-Oncogênicas c-raf/antagonistas & inibidores , Proteínas Proto-Oncogênicas c-raf/metabolismo , Tiazolidinas/síntese química , Tiazolidinas/farmacologiaRESUMO
Aeginetia indica Roxbert (Dok Din Daeng, DDD), a parasitic plant that grows on bamboo, is extensively used in Thai traditional medicine to treat various diseases. There have been no published studies on the pharmacological, toxicological or immunological effects of DDD, indigenous to Thailand. The study reported here was focused on the immunological effects (T cells) of the whole plant extract using water (WDDD) or ethanol (EDDD) as a solvent. The extracts were administered to female B6C3F1 mice by gavage for WDDD (10-100%) and intraperitoneally (i.p.) for EDDD (0.25-250 mg/kg) for 28 days. Only mice administrated the highest dose of EDDD exhibited an increase in absolute spleen and liver weights. Three T cell functional assays, including anti-CD3 antibody-mediated T cell proliferation, the mixed leukocyte response (MLR) and the cytotoxic T lymphocyte (CTL) response, were employed to determine the effects of DDD extracts on splenic T cell activities. Exposure to WDDD enhanced the responses in all three assays with significant changes observed in the anti-CD3 and MLR assays. Exposure to EDDD also enhanced the responses in all three assays with significant changes observed in the MLR and CTL assays. Additionally, significant increases in the MLR and anti-CD3 responses were also observed when EDDD was used to treat cells in vitro. Finally, exposure to WDDD decreased both the percentage and absolute number of regulatory CD4(+)CD25(+) T cells in the spleen, which was consistent with a significant increase in interferon-gamma (IFN-gamma) production from Con A-stimulated splenocytes. Overall, this study demonstrated that the extracts from A. indica Roxbert had a T cell stimulatory activity.
Assuntos
Adjuvantes Imunológicos/farmacologia , Orobanchaceae , Linfócitos T/imunologia , Animais , Peso Corporal/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Feminino , Técnicas In Vitro , Injeções Intraperitoneais , Contagem de Leucócitos , Fígado/patologia , Ativação Linfocitária , Teste de Cultura Mista de Linfócitos , Camundongos , Extratos Vegetais/farmacologia , Baço/citologia , Baço/efeitos dos fármacos , Linfócitos T/efeitos dos fármacos , TailândiaRESUMO
In the previous report, we have provided evidence that Aeginetia indica Roxbert (DDD) extracts enhance T cell-mediated immune responses. The study reported here was focused on the hematological and immunological effects, including B cells, natural killer (NK) cells, macrophages and neutrophils, of the whole plant extract using water (WDDD) or ethanol (EDDD) as the solvent. The extracts were administered to female B6C3F1 mice by gavage for WDDD (10-100%) and intraperitoneally for EDDD (0.25-250 mg/kg) for 28 days. In addition to hematological evaluation, several quantitative measures and functional assays (e.g., the splenic phenotypic analysis, IgM antibody-forming cell responses, natural killer cell activity, mononuclear phagocyte system [MPS] and neutrophil activity) were employed to examine the effects of DDD extracts on the innate and humoral immunities. The results from this study demonstrated that exposure to WDDD and EDDD produced minimal changes in the activities of B cells and natural killer cells, macrophages and neutrophils. Overall, hematological parameters were not affected by exposure to WDDD or EDDD. Taken together, the enhancing effect of DDD extracts on T cells may be primarily responsible for the successful and long-time use of this traditional herbal medicine in Thailand.